Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Suven Pharmaceuticals Ltd. ( (IN:SUVENPHAR) ) has provided an announcement.
Suven Pharmaceuticals Ltd. has announced that the audio recording of their conference call for the quarter and nine months ended December 31, 2024, is now available on their website. This move is part of the company’s commitment to maintaining transparency with its stakeholders, allowing investors to access detailed discussions on the company’s financial performance and strategic outlook.
More about Suven Pharmaceuticals Ltd.
Suven Pharmaceuticals Ltd. operates in the pharmaceutical industry, primarily focusing on the development and manufacture of active pharmaceutical ingredients and formulations. The company is headquartered in Mumbai, India, and has a corporate office in Hyderabad.
YTD Price Performance: -3.63%
Average Trading Volume: 9,113
Current Market Cap: 284.7B INR
Find detailed analytics on SUVENPHAR stock on TipRanks’ Stock Analysis page.